1214O Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)

Authors :: Alexandra Langlais
Olivier Molinier
Marie Wislez
J. Mazieres
Bernard Milleron
Armelle Lavolé
G. Zalcman
O. Carre
Laurent Brouchet
Jalal Assouad
Franck Morin
Gaelle Jeannin
R. Caliandro
Martine Antoine
Virginie Westeel
T. Egenod
Marie-Ange Massiani
Radj Gervais
F. Le Pimpec Barthes
Diane Damotte
Source :: Annals of Oncology. 31:S794
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Durvalumab
Multicenter study
business.industry
Internal medicine
medicine
non-small cell lung cancer (NSCLC)
Hematology
medicine.disease
business

Full Text Access

Tools